Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMLODIPINE\ATORVASTATIN\PERINDOPRIL: 17 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
17
Total FAERS Reports
6 (35.3%)
Deaths Reported
10
Hospitalizations
17
As Primary/Secondary Suspect
6
Life-Threatening

First Report: 20170102 · Latest Report: 20230102

What Are the Most Common AMLODIPINE\ATORVASTATIN\PERINDOPRIL Side Effects?

#1 Most Reported
Vomiting
7 reports (41.2%)
#2 Most Reported
Nausea
7 reports (41.2%)
#3 Most Reported
Systemic inflammatory response syndrome
6 reports (35.3%)

All AMLODIPINE\ATORVASTATIN\PERINDOPRIL Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Nausea 7 41.2% 6 6
Vomiting 7 41.2% 6 6
Asthenia 6 35.3% 6 6
Basal ganglia haemorrhage 6 35.3% 6 6
Blood lactate dehydrogenase increased 6 35.3% 6 6
Covid-19 pneumonia 6 35.3% 6 6
Fatigue 6 35.3% 6 6
Fibrin d dimer increased 6 35.3% 6 6
General physical health deterioration 6 35.3% 6 6
Somnolence 6 35.3% 6 6
Staphylococcal sepsis 6 35.3% 6 6
Systemic inflammatory response syndrome 6 35.3% 6 6

Who Reports AMLODIPINE\ATORVASTATIN\PERINDOPRIL Side Effects? Age & Gender Data

Gender: 46.2% female, 53.8% male. Average age: 76.2 years. Most reports from: DE. View detailed demographics →

Is AMLODIPINE\ATORVASTATIN\PERINDOPRIL Getting Safer? Reports by Year

YearReportsDeathsHosp.
2017 1 0 0
2018 2 0 2
2019 1 0 0
2021 1 0 1
2022 8 6 6
2023 1 0 0

View full timeline →

What Is AMLODIPINE\ATORVASTATIN\PERINDOPRIL Used For?

IndicationReports
Product used for unknown indication 14

Official FDA Label for AMLODIPINE\ATORVASTATIN\PERINDOPRIL

Official prescribing information from the FDA-approved drug label.